Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

20 Nov 2013 13:59

RECKITT BENCKISER GROUP PLC - Directorate Change

RECKITT BENCKISER GROUP PLC - Directorate Change

PR Newswire

London, November 20

20 November 2013 DIRECTORATE CHANGE Reckitt Benckiser Group plc (RB) today announces the appointment of NicandroDurante as an independent non-executive director, effective 1 December 2013 Mr Durante, Brazilian/Italian, is Chief Executive Officer of British AmericanTobacco. (BAT), a FTSE100 company with brands sold in 180 markets. Mr Durantehas had an extensive career at BAT which he joined in 1981. He has held variouscommercial and financial roles, becoming Chief Operating Officer in January2008 and Chief Executive Officer in March 2011. He brings experience of ahighly regulated and innovation-led industry, alongside extensive emergingmarkets' experience, having worked in Asia, Africa and Latin America. He addsfurther international diversity to the RB board. Adrian Bellamy, Chairman of RB, commented "The Board is delighted that Nicandro has agreed to join us. He will bring awealth of international consumer goods and financial knowledge to the Board andI am sure he will make a significant contribution to the future success of theCompany." There are no further details required to be disclosed pursuant to Listing Rule9.6.13 in connection with Mr Durante's appointment. For Further InformationAndraea Dawson-Shepherd SVP Global Corporate Communication and AffairsTelephone +44 (0) 1753 217 800 Liz Richardson Company SecretaryTelephone +44 (0) 1753 217 800 About Reckitt Benckiser (RB): Reckitt Benckiser (RB) is a global consumer goods leader in health, hygiene andhome. With a purpose of delivering innovative solutions for healthier lives andhappier homes, RB is in the top 25 of companies listed on the London StockExchange. Today it is the global No 1 or No 2 in the majority of itsfast-growing categories, driven by an exceptional rate of innovation. Itshealth, hygiene and home portfolio is led by 19 global Powerbrands includingNurofen, Strepsils Gaviscon, Mucinex, Durex, Scholl, Lysol, Dettol, Clearasil,Veet, Harpic, Bang, Mortein, Finish, Vanish, Woolite, Calgon, Air Wick, andFrench's. RB has close to half of its revenues coming from it 2 emerging marketAreas and just over half from its developed market Area. Over 70% of corerevenues come from the health and hygiene categories of the portfolio. RB people and its culture are at the heart of the company's success. They havean intense drive for achievement and a desire to outperform wherever theyfocus, including in sustainability where the company has reduced its carbonfootprint by 20% in 5 years and is now targeting to deliver a 1/3 reduction inwater impact, 1/3 further reduction in carbon and to have 1/3 of its netrevenue coming from more sustainable products by 2020. It is also the Save theChildren charity's largest FMCG global partner, with a new partnership visionto radically reduce the world's second biggest killer of under fives,diarrhoea. RB has been recognised as a sustainability leader in the CDP Global500 Carbon Performance Leadership Index and received a 2013 Sector MoverSustainability Award in the 10th Sustainability Yearbook. The company has operations in over 60 countries, with headquarters in the UK,Singapore, Dubai and Amsterdam, and sales in almost 200 countries, The companyemploys approximately 36,000 people worldwide.

For more information visit www.rb.com

Date   Source Headline
31st Mar 202110:00 amRNSRB rebrands as Reckitt
26th Mar 202112:30 pmRNSDirector/PDMR Shareholding
17th Mar 20213:00 pmRNSDirector/PDMR Shareholding
4th Mar 20212:30 pmRNSDirector/PDMR Shareholding
3rd Mar 202110:00 amRNSDirector/PDMR Shareholding
1st Mar 20213:00 pmRNSDirector/PDMR Shareholding
1st Mar 20212:16 pmRNSTotal Voting Rights
25th Feb 20213:20 pmRNSDirector/PDMR Shareholding
24th Feb 20217:01 amRNSDisposal
24th Feb 20217:01 amRNSAcquisition
24th Feb 20217:00 amRNSFinal Results
1st Feb 202111:42 amRNSTotal Voting Rights
4th Jan 202112:39 pmRNSTotal Voting Rights
30th Dec 20209:21 amRNSTR-1: Notification of major holdings
17th Dec 202010:45 amRNSDirectorate Change
1st Dec 202011:30 amRNSTotal Voting Rights
25th Nov 202011:30 amRNSDirector/PDMR Shareholding
23rd Nov 20204:30 pmRNSDirector/PDMR Shareholding
2nd Nov 202011:10 amRNSTotal Voting Rights
21st Oct 20202:00 pmRNSDirector/PDMR Shareholding
20th Oct 20204:35 pmRNSPrice Monitoring Extension
20th Oct 20207:00 amRNS3rd Quarter Results
7th Oct 20203:00 pmRNSDirector Declaration
5th Oct 20204:00 pmRNSDirector/PDMR Shareholding
1st Oct 20202:34 pmRNSDirector/PDMR Shareholding
1st Oct 202011:38 amRNSTotal Voting Rights
1st Sep 202010:22 amRNSTotal Voting Rights
26th Aug 20201:05 pmRNSDisclosure of rights attached to equity shares
25th Aug 20204:00 pmRNSDirector/PDMR Shareholding
3rd Aug 202012:08 pmRNSTotal Voting Rights
28th Jul 20207:00 amRNSHalf-year Report
1st Jul 20209:17 amRNSTotal Voting Rights
30th Jun 20205:00 pmRNSDirector Declaration
23rd Jun 202010:00 amRNSDirectorate Change
5th Jun 20204:30 pmRNSDirector/PDMR Shareholding
1st Jun 202011:01 amRNSTotal Voting Rights
29th May 20204:41 pmRNSSecond Price Monitoring Extn
29th May 20204:36 pmRNSPrice Monitoring Extension
29th May 20204:30 pmRNSDirector/PDMR Shareholding
29th May 202012:20 pmRNSDirector/PDMR Shareholding
28th May 20202:29 pmRNSDirector/PDMR Shareholding
13th May 20205:46 pmRNSDirector/PDMR Shareholding
13th May 20202:07 pmRNSPublication of Offering Memorandum
12th May 20206:01 pmRNSIssue of Debt
12th May 20204:55 pmRNSResult of AGM
12th May 20204:15 pmRNSDirectorate Change
4th May 20202:10 pmRNSDirector/PDMR Shareholding
1st May 20204:41 pmRNSDirector/PDMR Shareholding
1st May 202011:38 amRNSTotal Voting Rights
30th Apr 20207:00 amRNSQ1 2020 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.